Ind Swift Laboratories

106.50
-0.50
(-0.47%)
Market Cap (₹ Cr.)
₹632
52 Week High
186.00
Book Value
₹
52 Week Low
86.20
PE Ratio
6.30
PB Ratio
0.64
PE for Sector
42.42
PB for Sector
4.03
ROE
%
ROCE
67.05 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
6.89 %
Net Income Growth
781.80 %
Cash Flow Change
-183.81 %
ROE
545.51 %
ROCE
445.12 %
EBITDA Margin (Avg.)
6.71 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
159
177
167
154
162
184
170
179
176
168
188
171
222
207
178
249
205
187
200
204
197
210
227
227
220
248
237
248
297
279
295
311
278
305
278
283
794
42
16
Expenses
189
146
136
126
137
154
140
146
149
148
155
133
170
149
128
159
149
144
159
157
149
161
173
173
177
191
175
189
241
219
231
247
207
239
207
222
309
35
15
EBITDA
-31
31
32
28
24
30
30
34
27
20
33
39
52
58
49
89
56
43
41
47
48
49
54
54
44
57
62
60
56
60
64
64
71
65
71
61
484
7
1
Operating Profit %
-29 %
14 %
16 %
16 %
15 %
14 %
16 %
15 %
12 %
10 %
16 %
20 %
21 %
17 %
19 %
19 %
22 %
21 %
16 %
20 %
19 %
21 %
22 %
22 %
19 %
21 %
24 %
22 %
13 %
20 %
20 %
18 %
23 %
20 %
23 %
20 %
19 %
-15 %
-443 %
Depreciation
33
21
21
21
21
22
22
22
22
22
21
22
21
25
26
25
28
23
23
23
22
20
20
20
28
14
14
21
82
16
16
15
13
14
13
14
13
0
0
Interest
31
26
26
24
37
25
23
21
20
21
19
17
-29
5
23
22
27
28
29
29
21
25
25
25
24
24
24
24
24
24
24
22
21
20
21
21
-12
0
0
Profit Before Tax
-95
-16
-16
-17
-34
-17
-14
-9
-16
-23
-7
0
59
28
1
42
1
-8
-11
-5
4
4
9
9
-9
19
24
15
-50
20
24
27
37
31
37
27
483
6
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
11
0
0
0
25
0
0
-3
6
14
6
5
144
0
0
Net Profit
-71
-16
-16
-17
-10
-17
-14
-9
0
-23
-7
0
48
28
1
42
-20
-8
-11
-5
3
4
9
9
-29
19
24
15
-63
20
24
29
30
17
30
22
350
6
0
EPS in ₹
-17.31
-3.98
-3.83
-4.23
-2.33
-4.08
-3.52
-2.02
0.10
-5.13
-1.65
0.02
10.63
6.08
0.29
9.11
-4.01
-1.70
-2.29
-1.05
0.59
0.71
1.56
1.56
-4.91
3.17
4.04
2.52
-10.69
3.41
4.07
4.95
5.09
2.89
5.09
3.66
59.17
1.05
0.05

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,238
2,210
2,121
1,997
1,913
1,860
1,817
1,803
1,788
1,105
Fixed Assets
1,114
1,096
1,042
934
914
843
752
630
587
8
Current Assets
906
909
808
809
817
845
866
998
1,074
546
Capital Work in Progress
115
82
70
69
20
12
19
10
8
0
Investments
0
0
26
26
26
26
55
111
85
166
Other Assets
1,009
1,033
982
968
953
980
991
1,052
1,108
931
Total Liabilities
2,238
2,210
2,121
1,997
1,913
1,860
1,817
1,803
1,788
1,105
Current Liabilities
830
949
994
920
342
309
287
314
350
178
Non Current Liabilities
816
746
601
534
980
906
892
857
763
4
Total Equity
592
515
526
543
590
645
639
633
675
922
Reserve & Surplus
551
473
480
497
542
585
579
573
616
863
Share Capital
42
42
46
46
48
60
60
60
60
59

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
3
-7
-8
23
-20
1
-1
1
416
Investing Activities
-37
-30
-31
-17
-2
-10
-10
3
-14
-104
Operating Activities
100
80
93
72
-75
123
135
136
183
-180
Financing Activities
-64
-48
-69
-62
100
-133
-124
-140
-168
700

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Promoter
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.17 %
0.00 %
0.25 %
1.26 %
0.85 %
0.65 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
0.00 %
8.03 %
0.94 %
0.94 %
0.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.38 %
27.72 %
26.78 %
29.03 %
29.21 %
29.31 %
29.55 %
29.06 %
28.97 %
29.08 %
29.20 %
28.77 %
29.26 %
30.46 %
36.69 %
36.80 %
36.63 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,841.35 4,36,439.00 38.90 49,887.20 12.06 9,648 27.34 59.05
1,490.55 1,19,175.70 25.82 26,520.70 14.17 4,155 12.95 50.71
2,916.65 1,16,611.50 56.78 10,615.60 19.57 1,942 28.89 63.62
1,355.15 1,12,712.30 21.12 28,905.40 12.36 5,578 -9.47 71.05
2,182.10 98,956.70 37.66 20,141.50 19.94 1,936 73.53 60.05
957.65 97,081.50 22.69 19,831.50 13.82 3,831 14.57 42.02
1,256.25 73,323.30 20.28 29,559.20 17.55 3,169 8.66 48.45
5,408.60 64,640.40 29.75 12,978.40 9.84 1,812 14.16 41.69
1,541.45 43,338.50 - 12,653.10 6.58 -1,831 675.49 48.19
346.45 41,360.70 29.70 15,621.20 35.25 1,298 -84.31 47.70

Corporate Action

Technical Indicators

RSI(14)
Neutral
47.29
ATR(14)
Less Volatile
2.78
STOCH(9,6)
Oversold
14.14
STOCH RSI(14)
Neutral
20.08
MACD(12,26)
Bullish
0.06
ADX(14)
Weak Trend
20.80
UO(9)
Bearish
40.48
ROC(12)
Downtrend And Accelerating
-7.19
WillR(14)
Oversold
-89.73